Lack of pathogenic involvement of CCL4 and its receptor CCR5 in arthritogenic alphavirus disease
ImmunoHorizons · 2025
DOI: 10.1093/immhor/vlaf022 ↗Kurz gefasst
Fachartikel in der Zeitschrift ImmunoHorizons, 2025. Verfasst von Muddassar Hameed und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA, United States. Hauptthemen laut MEDLINE: Receptors, CCR5, Alphavirus Infections, Chemokine CCL4, Alphavirus. Die Arbeit nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAID NIH HHS, NIAID.
Abstract (Originalsprache)
Arthritogenic alphaviruses, including chikungunya (CHIKV), Mayaro (MAYV), Ross River (RRV), and O’nyong nyong virus (ONNV), are emerging and reemerging viruses that cause disease characterized by fever, rash, and incapacitating muscle and joint pain and inflammation. Alphavirus infection induces robust immune responses, leading to the upregulation of several cytokines and chemokines, including chemokine C ligand 4 (CCL4). CCL4 is a chemoattractant for immune cells such as T cells, natural killer cells, monocytes/macrophages, and dendritic cells, recruiting these cells to the site of infection, stimulating the release of proinflammatory mediators, and inducing T cell differentiation. CCL4 has been found at high levels in both the acute and chronic phases of chikungunya disease; however, the role of CCL4 in arthritogenic alphavirus disease development remains unexplored. Here, we tested the effect of CCL4 on MAYV infection in mice through antibody neutralization and treatment with recombinant mouse CCL4. We observed no differences in mice depleted of CCL4 or treated with recombinant CCL4 in terms of disease progression such as weight loss and footpad swelling or the development of viremia. CCL4 uses the G protein-coupled receptor C-C chemokine receptor type 5 (CCR5). To determine whether CCR5 deficiency would alter disease outcomes or virus replication in mice, we inoculated CCR5 knockout (CCR5−−) mice with MAYV and observed no effect on disease development and immune cell profile of blood and footpads between CCR5−/− and wild type mice. These studies failed to identify a clear role for CCL4 or its receptor CCR5 in MAYV infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA, United States.
- Center for Zoonotic and Arthropod-borne Pathogens, Virginia Polytechnic Institute and State University, Blacksburg, VA, United States.
- Lead contact: 1410 Prices Fork Rd., Blacksburg, VA, 24060, United States, weger@vt.edu.
ORCID-Profile: Norman A Solomon, James Weger-Lucarelli
Förderung
- NIAID NIH HHS
- NIAID
Zitieren
APA
Hameed, M., Solomon, N. A., & Weger-Lucarelli, J. (2025). Lack of pathogenic involvement of CCL4 and its receptor CCR5 in arthritogenic alphavirus disease. ImmunoHorizons. https://doi.org/10.1093/immhor/vlaf022
Vancouver
Hameed M, Solomon NA, Weger-Lucarelli J. Lack of pathogenic involvement of CCL4 and its receptor CCR5 in arthritogenic alphavirus disease. ImmunoHorizons. 2025. doi:10.1093/immhor/vlaf022
BibTeX
@article{Hameed2025,
author = {Hameed, Muddassar and Solomon, Norman A and Weger-Lucarelli, James},
title = {Lack of pathogenic involvement of CCL4 and its receptor CCR5 in arthritogenic alphavirus disease},
journal = {ImmunoHorizons},
year = {2025},
doi = {10.1093/immhor/vlaf022}
}
EUVIMED